Finn von Eyben | oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Finn von Eyben | oncology | Best Researcher Award

chief, Center of Tobacco Control Reearch, Denmark.

Dr. Finn Edler von Eyben is a renowned specialist in internal medicine and oncology, with significant expertise across Denmark, Norway, and Sweden. He previously served as an administrative consultant at the Department of Internal Medicine, Queen Ingrid’s Hospital, Nuuk, Greenland. Dr. von Eyben is the author of multiple pivotal publications on testis cancer and prostate cancer, particularly in the field of radioligand therapy using PSMA. With a remarkable 12,914 reads and 2,788 citations of his work, he has made substantial contributions to oncological research. He has been invited to present at major international conferences, including those hosted at Innsbruck University, Austria. A prolific researcher, he also edited a theme issue on PSMA and prostate cancer for the International Journal of Molecular Sciences. His work spans over 164 publications, making him a leading figure in modern cancer research.

Profile:

Scopus

Education:

Dr. Finn Edler von Eyben completed his Doctor of Medicine at Southern Sweden in 1985, specializing in tumor markers for testicular cancer. Later, in 2005, he furthered his education at Southern Denmark, continuing his work on tumor markers for testis cancer. His educational foundation has been instrumental in shaping his deep understanding of cancer research, specifically in oncology and internal medicine. The combination of clinical and research-based education has allowed him to make lasting contributions to the medical field, focusing on advanced therapeutic techniques, radioligand therapy, and cancer biomarkers. Throughout his career, Dr. von Eyben has remained committed to advancing medical education through his research, aiming to provide a strong scientific basis for improving clinical outcomes in cancer care.

Experience:

Dr. Finn Edler von Eyben has built an extensive career in internal medicine and oncology across several countries, including Denmark, Norway, and Sweden. His administrative consultant role at the Department of Internal Medicine, Queen Ingrid’s Hospital in Nuuk, Greenland, showcased his leadership abilities in healthcare administration. With over three decades of clinical experience, Dr. von Eyben has been involved in groundbreaking cancer research and therapy, particularly concerning testis and prostate cancers. As a recognized authority, he has been a frequent speaker at international conferences, contributing his insights on PSMA and its role in prostate cancer treatment. His research focus on serum tumor markers and PSMA-based radioligand therapy has been widely influential, with his work being referenced globally. His expertise also extends to serving as the editor of journals and collaborating with fellow researchers, solidifying his position as a thought leader in oncology.

Awards and Honors:

Dr. Finn Edler von Eyben has earned widespread recognition for his outstanding contributions to oncology and internal medicine. His groundbreaking research on testis cancer and prostate cancer therapies has garnered over 2,788 citations, reflecting the high regard in which he is held by the scientific community. He was invited to serve as an editor for the International Journal of Molecular Sciences, where he contributed significantly to the PSMA and prostate cancer theme issue. His career has been marked by numerous invitations to deliver oral presentations at prestigious international conferences on nuclear medicine in oncology, including at Innsbruck University, Austria. Additionally, Dr. von Eyben’s research on radioligand therapy has positioned him at the forefront of the treatment of metastatic prostate cancer. While he has not publicly listed specific formal awards, the high citation index and frequent invitations to speak at conferences underscore the esteem he commands within the field.

Research Focus:

Dr. Finn Edler von Eyben is primarily focused on the treatment and diagnostic aspects of prostate cancer and testicular cancer. His research has greatly contributed to understanding tumor markers, especially in testis cancer, and has advanced the field of PSMA (Prostate-Specific Membrane Antigen)-based radioligand therapy. His notable work includes studies on 177Lu-PSMA-617 radioligand therapy for metastatic prostate cancer, which has revolutionized treatment strategies for castration-resistant prostate cancer. Dr. von Eyben has authored influential systematic reviews on the use of PSMA PET/CT scans in prostate cancer management, offering critical insights into optimal treatment regimens and early detection. Furthermore, his meta-analyses of choline PET/CT imaging for prostate cancer have solidified his role as a leader in nuclear medicine oncology. His work continues to shape clinical practices, focusing on personalized cancer treatments and improving patient outcomes through precision medicine.

Publication Titles:

  • 177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer 🏥🔬
  • Third-line treatment and (177)Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review 📚🧪
  • (177)Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer 🧬⚙️
  • Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with (177)Lu-PSMA radioligand therapy ⏳🎯
  • (68)Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis 📊🧠
  • Meta-analysis of (11)C-choline and (18)F-choline PET/CT for management of patients with prostate cancer 💡💊
  • Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review 🧪💉
  • Review on the Increasing Role for PSMA-Based Radioligand Therapy in Prostate Cancer 🏆📈

 

 

John Tsiaoussis | Translational Oncology | Best Paper Award

Posted on by ScienceFather

Prof. John Tsiaoussis | Translational Oncology | Best Paper Award

John Tsiaoussis at School of Medicine, University of Crete, Greece

Dr. John C. Tsiaoussis is a distinguished Professor of Anatomy at the University of Crete’s School of Medicine, where he also serves as Head of the Department of Anatomy and Director of the Museum of Medicine. With a robust academic background, Dr. Tsiaoussis has delivered over 100 invited lectures at international and national conferences. His prolific research output includes more than 100 publications in peer-reviewed journals, garnering around 3,500 citations and an H-index of 33. His work emphasizes the importance of anatomical education and research in enhancing medical practice, particularly in understanding colorectal cancer. Dr. Tsiaoussis actively engages in editorial roles across multiple medical journals, furthering the discourse in surgical and functional anatomy. His commitment to advancing medical knowledge and education makes him a leading figure in his field.

Profile:

Scopus Profile

Strengths for the Award:

  1. Extensive Publication Record:
    • Over 100 publications in peer-reviewed journals and 6 book chapters, showcasing a strong commitment to research and knowledge dissemination.
  2. High Citation Impact:
    • 3,500 citations with an H-index of 33 indicate significant recognition and impact within the scientific community.
  3. Diverse Research Interests:
    • Focus on important areas like biomarkers in colorectal cancer and surgical anatomy, contributing to significant advancements in understanding and treatment.
  4. Leadership Roles:
    • As Head of Department and Director of the Museum of Medicine, demonstrates leadership in academia and commitment to education and research.
  5. Invited Lectures:
    • Over 100 invited lectures at national and international events, reflecting expertise and reputation in the field.
  6. Editorial Contributions:
    • Long-standing role as Editor and Guest Editor in respected journals, contributing to the peer review process and the advancement of medical research.

Areas for Improvement:

  1. Broader Research Collaboration:
    • While Dr. Tsiaoussis has a strong individual publication record, seeking out more interdisciplinary collaborations could enhance the breadth and impact of his research.
  2. Engagement with Emerging Technologies:
    • Exploring the integration of advanced technologies (e.g., AI, machine learning) in research could provide innovative approaches to his work in cancer biomarkers and surgical anatomy.
  3. Increased Public Outreach:
    • Enhancing efforts to translate research findings to the general public could improve awareness and understanding of colorectal cancer and surgical practices.

Education:

Dr. Tsiaoussis obtained his medical degree from the University of Crete, where he demonstrated exceptional academic performance and a keen interest in anatomy. He continued his education with a specialization in anatomy, gaining a comprehensive understanding of both surgical and functional aspects. His academic journey was marked by rigorous training and research, which laid the groundwork for his later contributions to the field. Dr. Tsiaoussis pursued further training and certifications that expanded his expertise in anatomical sciences, including advanced techniques in surgical anatomy. His educational background is complemented by numerous workshops and training sessions, allowing him to remain at the forefront of medical education. Dr. Tsiaoussis is committed to lifelong learning and regularly updates his skills to incorporate the latest advancements in medical science into his teaching and research methodologies.

Experience:

Dr. John C. Tsiaoussis has an extensive academic and clinical background that spans several decades. As the Head of the Department of Anatomy at the University of Crete, he has been instrumental in shaping the curriculum and research direction within the department. His role includes overseeing educational programs, mentoring students, and facilitating collaborative research efforts. He has held numerous editorial positions in esteemed medical journals, contributing to the peer-review process and enhancing the quality of published research. Dr. Tsiaoussis’s experience extends to delivering over 100 invited lectures globally, sharing his expertise in anatomical research and colorectal cancer biomarkers. His involvement in international symposiums and workshops underscores his dedication to advancing medical education and research. He is recognized for his leadership in fostering a dynamic academic environment that encourages innovation and excellence in the field of anatomy and surgery.

Research Focus:

Dr. Tsiaoussis’s research primarily centers on biomarkers in colorectal cancer and surgical and functional anatomy. His work explores the intricate relationship between microbial DNA and cancer progression, particularly the role of Fusobacterium nucleatum in colorectal cancer patients. He is actively investigating the gut microbiome’s composition and its implications for treatment outcomes in stages II and III colorectal cancer. Additionally, his research extends to the anatomical intricacies involved in surgical procedures, aiming to enhance surgical outcomes through improved understanding of anatomy. Dr. Tsiaoussis’s interdisciplinary approach combines molecular biology, clinical research, and surgical education, contributing valuable insights to the medical community. His publications reflect a commitment to advancing knowledge that directly impacts clinical practice and patient care. Through his ongoing research efforts, Dr. Tsiaoussis strives to bridge the gap between basic science and clinical applications, making significant contributions to the field of translational oncology.

Publication Top Notes:

  1. Circulating Bacterial DNA in Colorectal Cancer Patients: The Potential Role of Fusobacterium nucleatum 📄
  2. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy 🌐
  3. Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis 🔍
  4. Evaluation of a Quality Improvement Intervention to Reduce Anastomotic Leak Following Right Colectomy (EAGLE) 📊
  5. Spinal Accessory Nerve Anatomy in the Posterior Cervical Triangle: A Systematic Review with Meta-Analysis 📚
  6. Online Tours for a Museum of Medicine 🌍
  7. Unraveling the Role of Molecular Profiling in Predicting Treatment Response in Stage III Colorectal Cancer Patients: Insights from the IDEA International Study 📈
  8. Ultrasound Morphometry of the Cervical Vagus Nerve for Daily Clinical Practice: Reference Values for Cross Sectional Area and Fascicle Count 📏
  9. Role of Telomere Length in Human Carcinogenesis (Review) 🧬
  10. Achieving a Textbook Outcome in Colon Cancer Surgery Is Associated with Improved Long-Term Survival 📅

Conclusion:

Dr. John C. Tsiaoussis demonstrates exceptional qualifications for the Research for Best Researcher Award through his prolific publication record, impactful research, and leadership within the academic community. His contributions to the fields of anatomy and cancer research are significant, and he shows potential for further growth in interdisciplinary collaboration and public engagement. Recognizing his efforts with this award would not only honor his achievements but also inspire further innovation in medical research.